StonvexLoading…
StonvexStonvexStonvexCore line items from SCSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.27B | $1.51B | $739.65M | $3.04B |
Operating Income | $66.89M | $43.77M | $25.90M | $85.20M |
Net Income | $53.26M | $16.49M | $19.88M | $71.55M |
EPS (Diluted) | $2.42 | $1.63 | $0.89 | $3.00 |
Total Assets | $1.81B | $1.74B | $1.72B | $1.79B |
Total Liabilities | $899.50M | $830.78M | $802.94M | $879.20M |
Cash & Equivalents | $120.30M | $83.47M | $124.92M | $126.16M |
Free Cash Flow OCF − CapEx | $118.63M | $49.68M | $20.82M | $104.06M |
Shares Outstanding | 20.78M | 21.65M | 22.07M | 22.22M |